Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
2.680
+0.090 (3.47%)
Nov 5, 2024, 1:16 PM EST - Market open

Protara Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
55213076271-
Upgrade
Market Cap Growth
58.47%-29.43%-60.18%-72.06%--
Upgrade
Enterprise Value
-31-47-70-55106-
Upgrade
Last Close Price
2.591.882.686.7524.21-
Upgrade
PE Ratio
--0.53-0.46-1.60-5.15-
Upgrade
PB Ratio
0.580.310.300.471.36-
Upgrade
P/FCF Ratio
-1.28-0.57-1.14-2.16-11.17-
Upgrade
P/OCF Ratio
-1.29-0.57-1.14-2.20-11.60-
Upgrade
EV/EBITDA Ratio
0.161.091.881.16-3.10-
Upgrade
EV/EBIT Ratio
0.161.081.871.16-3.09-
Upgrade
EV/FCF Ratio
0.211.252.641.57-4.38-
Upgrade
Debt / Equity Ratio
0.050.080.060.040.01-
Upgrade
Debt / FCF Ratio
-0.15-0.15-0.24-0.21-0.04-
Upgrade
Quick Ratio
15.8610.7014.7821.3757.840.17
Upgrade
Current Ratio
16.3311.1715.0121.6658.130.23
Upgrade
Return on Equity (ROE)
-45.90%-47.44%-49.96%-26.17%-34.48%-591.11%
Upgrade
Return on Assets (ROA)
-28.11%-28.36%-16.42%-15.80%-21.07%-143.64%
Upgrade
Return on Capital (ROIC)
-29.39%-29.91%-16.90%-16.07%-21.72%-369.45%
Upgrade
Earnings Yield
-76.15%-189.67%-218.41%-62.30%-12.52%-
Upgrade
FCF Yield
-62.55%-176.45%-88.01%-46.28%-8.95%-
Upgrade
Buyback Yield / Dilution
-22.64%-0.64%-0.24%-55.28%-180.66%76.99%
Upgrade
Total Shareholder Return
-22.64%-0.64%-0.24%-55.28%-180.66%76.99%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.